These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28750807)

  • 1. Approaches to Assess Biased Signaling at the CB1R Receptor.
    Laprairie RB; Stahl EL; Bohn LM
    Methods Enzymol; 2017; 593():259-279. PubMed ID: 28750807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
    Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications.
    Kulkarni AR; Garai S; Janero DR; Thakur GA
    Methods Enzymol; 2017; 593():281-315. PubMed ID: 28750808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
    Khajehali E; Malone DT; Glass M; Sexton PM; Christopoulos A; Leach K
    Mol Pharmacol; 2015 Aug; 88(2):368-79. PubMed ID: 26044547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
    Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.
    Khurana L; Mackie K; Piomelli D; Kendall DA
    Neuropharmacology; 2017 Sep; 124():3-12. PubMed ID: 28527758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants.
    Gyombolai P; Tóth AD; Tímár D; Turu G; Hunyady L
    J Mol Endocrinol; 2015 Feb; 54(1):75-89. PubMed ID: 25510402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Allosteric Modulation of CB
    Scott CE; Kendall DA
    Methods Enzymol; 2017; 593():317-342. PubMed ID: 28750809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB1 Cannabinoid Receptor Signaling and Biased Signaling.
    Leo LM; Abood ME
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
    Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
    Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor.
    Laprairie RB; Kulkarni PM; Deschamps JR; Kelly MEM; Janero DR; Cascio MG; Stevenson LA; Pertwee RG; Kenakin TP; Denovan-Wright EM; Thakur GA
    ACS Chem Neurosci; 2017 Jun; 8(6):1188-1203. PubMed ID: 28103441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities.
    Hryhorowicz S; Kaczmarek-Ryś M; Andrzejewska A; Staszak K; Hryhorowicz M; Korcz A; Słomski R
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias.
    Manning JJ; Green HM; Glass M; Finlay DB
    Neuropharmacology; 2021 Aug; 193():108611. PubMed ID: 34000272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerted action of CB1 cannabinoid receptor and deleted in colorectal cancer in axon guidance.
    Argaw A; Duff G; Zabouri N; Cécyre B; Chainé N; Cherif H; Tea N; Lutz B; Ptito M; Bouchard JF
    J Neurosci; 2011 Jan; 31(4):1489-99. PubMed ID: 21273433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomer-specific positive allosteric modulation of CB
    Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
    Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of type 1 cannabinoid receptor allosteric ligands.
    Alaverdashvili M; Laprairie RB
    Drug Metab Rev; 2018 Feb; 50(1):14-25. PubMed ID: 29355038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.